Arecor Therapeutics plc (FRA:6UI)

Arecor Therapeutics Revenue

Arecor Therapeutics had revenue of 2.00M GBP in the half year ending June 30, 2025, with 20.01% growth. This brings the company's revenue in the last twelve months to 5.06M, up 3.31% year-over-year. In the year 2024, Arecor Therapeutics had annual revenue of 5.05M with 10.50% growth.

• Revenue (ttm): 5.06M GBP
• Revenue Growth: +3.31%
• P/S Ratio: 6.02
• Revenue / Employee: 115.02K GBP
• Employees: 44
• Market Cap: 35.53M EUR

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.05M	480.00K	10.50%
Dec 31, 2023	4.57M	2.17M	90.30%
Dec 31, 2022	2.40M	1.25M	107.51%
Dec 31, 2021	1.16M	-540.00K	-31.80%
Dec 31, 2020	1.70M	-192.99K	-10.21%